Axial Biotech Launches Scoliscore AIS Prognostic Test for Scoliosis

Axial Biotech has launched its Scoliscore AIS Prognostic Test for scoliosis, to be marketed by DePuy Spine, according to a release from Axial Biotech.

Advertisement

Scoliscore AIS is a saliva-based genetic test to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.

Read Axial Biotech’s release about its Scoliscore AIS Prognostic Test.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.